drugset / Trial / NCT04302519

Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells

NCT04302519

Phase 0 Unknown 24 enrolled CAR-T (Shanghai) Biotechnology Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Evaluation of novel coronavirus induced severe pneumonia by dental pulp mesenchymal stem cells

Timeline

Start
2020-03-05
Primary completion
2021-06-30
Completion
2021-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dental pulp mesenchymal stem cells Cell therapy 1e+06 cells/kg

Indications